CLC Bio Opens up Informatics Platform to Third-Party Developers, Taps Omixon as First Partner

In an attempt to meet the demand for niche bioinformatics applications — particularly for next-generation sequencing — CLC Bio is reaching out to third-party developers to create software that targets more specialized markets.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.